Tangelder, M.J.

nsaid patient risk factors study factor strategy inhibitor prescription h 2ra misoprostol non-speci fic nsaids ulcer cox -2-speci inhibitors -2-speci risk factor agent nsaid users flammatory prevalence population complication prophylactic anti-in cox -2-speci inhibitor ugi ulcer complications non-speci gastroprotective nonsteroidal kong sx gastroprotective agents prevention 12- month period history database h 2ras result therapy study population analysis arthritis table coprescription month record netherland guideline period disease fi xed combination outcome ugi risk factors grants /research support cox -2speci inhibitors cox 2-speci inhibitors index nsaid prescription nsaid-associated ulcer complications indication prophylactic h 2ra fi ndings gi prevention subject prophylactic use ulcer complications osteoarthritis -2-preferential suppl utilization sturkenboom health dyspepsia chart review cox -2-preferential agents identi fied referent speci fically acid-suppressive drugs american college medication gastroduodenal study period